ValuEngine lowered shares of MetLife, Inc. (NYSE:MET) from a strong-buy rating to a buy rating in a research note released on Tuesday morning.

Several other equities analysts also recently weighed in on MET. Zacks Investment Research upgraded shares of MetLife from a strong sell rating to a hold rating in a report on Monday. TheStreet upgraded shares of MetLife from a c+ rating to a b rating in a report on Wednesday, October 4th. Morgan Stanley increased their price target on shares of MetLife from $54.00 to $55.00 and gave the stock an equal weight rating in a report on Thursday, October 5th. Wells Fargo & Company reiterated an outperform rating and issued a $60.00 price target (up previously from $55.00) on shares of MetLife in a report on Tuesday, October 3rd. They noted that the move was a valuation call. Finally, Royal Bank Of Canada reiterated a buy rating and issued a $56.00 price target on shares of MetLife in a report on Wednesday, September 6th. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating and nine have assigned a buy rating to the company’s stock. MetLife has an average rating of Hold and a consensus price target of $57.38.

Shares of MetLife (MET) traded up 0.358% during mid-day trading on Tuesday, hitting $52.919. 675,272 shares of the stock were exchanged. MetLife has a 52-week low of $40.30 and a 52-week high of $53.30. The firm has a market cap of $56.25 billion, a price-to-earnings ratio of 622.576 and a beta of 1.47. The stock has a 50-day moving average price of $49.82 and a 200 day moving average price of $47.85.

MetLife (NYSE:MET) last announced its quarterly earnings data on Wednesday, August 2nd. The financial services provider reported $1.30 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.28 by $0.02. The firm had revenue of $17.39 billion during the quarter, compared to analyst estimates of $17.11 billion. MetLife had a net margin of 0.30% and a return on equity of 8.51%. MetLife’s revenue was up 2.5% on a year-over-year basis. During the same period last year, the firm posted $0.83 EPS. On average, equities research analysts expect that MetLife will post $4.62 earnings per share for the current year.

ILLEGAL ACTIVITY NOTICE: This piece was first published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this piece on another publication, it was copied illegally and reposted in violation of United States & international copyright law. The correct version of this piece can be read at https://www.thecerbatgem.com/2017/10/13/metlife-inc-met-downgraded-by-valuengine.html.

Several hedge funds and other institutional investors have recently modified their holdings of the company. Intl Fcstone Inc. acquired a new stake in shares of MetLife during the 2nd quarter worth approximately $383,000. Griffin Asset Management Inc. acquired a new stake in MetLife in the 2nd quarter valued at $2,424,000. Farmers National Bank acquired a new stake in MetLife in the 2nd quarter valued at $118,000. RNC Capital Management LLC grew its stake in MetLife by 3.9% in the 2nd quarter. RNC Capital Management LLC now owns 427,056 shares of the financial services provider’s stock valued at $23,462,000 after acquiring an additional 16,100 shares during the period. Finally, Sentry Investment Management LLC grew its stake in MetLife by 0.8% in the 2nd quarter. Sentry Investment Management LLC now owns 82,321 shares of the financial services provider’s stock valued at $4,523,000 after acquiring an additional 690 shares during the period. 74.25% of the stock is currently owned by institutional investors and hedge funds.

MetLife Company Profile

MetLife, Inc is a provider of life insurance, annuities, employee benefits and asset management. The Company’s segments include U.S.; Asia; Latin America; Europe, the Middle East and Africa (EMEA); MetLife Holdings, and Corporate & Other. Its U.S. segment is organized into Group Benefits, Retirement and Income Solutions and Property & Casualty businesses.

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for MetLife (NYSE:MET)

Receive News & Stock Ratings for MetLife Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife Inc. and related stocks with our FREE daily email newsletter.